MedKoo Cat#: 581928 | Name: Propylene glycol monocaprate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Propylene glycol monocaprate is a biochemical.

Chemical Structure

Propylene glycol monocaprate
Propylene glycol monocaprate
CAS#68795-69-7

Theoretical Analysis

MedKoo Cat#: 581928

Name: Propylene glycol monocaprate

CAS#: 68795-69-7

Chemical Formula: C13H28O4

Exact Mass: 248.2000

Molecular Weight: 248.36

Elemental Analysis: C, 62.87; H, 11.36; O, 25.77

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Propylene glycol monocaprate; Decanoic acid, monoester with 1,2-propanediol; decanoic acid compound with propane-1,2-diol (1:1)
IUPAC/Chemical Name
decanoic acid compound with propane-1,2-diol (1:1)
InChi Key
PHMQYKDOTWAOBI-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H20O2.C3H8O2/c1-2-3-4-5-6-7-8-9-10(11)12;1-3(5)2-4/h2-9H2,1H3,(H,11,12);3-5H,2H2,1H3
SMILES Code
CCCCCCCCCC(=O)O.CC(O)CO
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 248.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Khalid N, Sarfraz M, Arafat M, Akhtar M, Löbenberg R, Ur Rehman N. Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs. J Pharm Pharm Sci. 2018;21(1):398-408. doi: 10.18433/jpps30097. PubMed PMID: 30365396. 2: Gazga-Urioste C, Rivera-Becerril E, Pérez-Hernández G, Angélica Noguez-Méndez N, Faustino-Vega A, Tomás Quirino-Barreda C. Physicochemical characterization and thermal behavior of hexosomes containing ketoconazole as potential topical antifungal delivery system. Drug Dev Ind Pharm. 2019 Jan;45(1):168-176. doi: 10.1080/03639045.2018.1526188. Epub 2018 Oct 17. PubMed PMID: 30231655. 3: Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME. Topical delivery of anthramycin II. Influence of binary and ternary solvent systems. Eur J Pharm Sci. 2018 Aug 30;121:59-64. doi: 10.1016/j.ejps.2018.05.002. Epub 2018 May 7. PubMed PMID: 29746912. 4: Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions. Pharm Res. 2018 Jan 5;35(1):25. doi: 10.1007/s11095-017-2316-y. PubMed PMID: 29305717. 5: Ćetković Z, Cvijić S, Vasiljević D. In vitro/in silico approach in the development of simvastatin-loaded self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2018 May;44(5):849-860. doi: 10.1080/03639045.2017.1414835. Epub 2017 Dec 19. PubMed PMID: 29228833. 6: Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME. Topical delivery of anthramycin I. Influence of neat solvents. Eur J Pharm Sci. 2017 Jun 15;104:188-195. doi: 10.1016/j.ejps.2017.03.043. Epub 2017 Mar 31. PubMed PMID: 28373034. 7: Parisi N, Paz-Alvarez M, Matts PJ, Lever R, Hadgraft J, Lane ME. Topical delivery of hexamidine. Int J Pharm. 2016 Jun 15;506(1-2):332-9. doi: 10.1016/j.ijpharm.2016.04.069. Epub 2016 Apr 26. PubMed PMID: 27130367. 8: Chakravarty P, Kothari S, Deese A, Lubach JW. Solid-State Characterization of Novel Propylene Glycol Ester Solvates Isolated from Lipid Formulations. Mol Pharm. 2015 Jul 6;12(7):2551-7. doi: 10.1021/mp5007695. Epub 2015 Jun 3. PubMed PMID: 26013841. 9: Hirata K, Mohammed D, Hadgraft J, Lane ME. Influence of lidocaine hydrochloride and penetration enhancers on the barrier function of human skin. Int J Pharm. 2014 Dec 30;477(1-2):416-20. doi: 10.1016/j.ijpharm.2014.10.012. Epub 2014 Oct 8. PubMed PMID: 25305378. 10: Cheong KW, Mirhosseini H, Hamid NS, Osman A, Basri M, Tan CP. Effects of propylene glycol alginate and sucrose esters on the physicochemical properties of modified starch-stabilized beverage emulsions. Molecules. 2014 Jun 24;19(6):8691-706. doi: 10.3390/molecules19068691. PubMed PMID: 24962400; PubMed Central PMCID: PMC6270833. 11: Lee KE, Choi YJ, Oh BR, Chun IK, Gwak HS. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems. Int J Pharm. 2013 Nov 18;456(2):432-6. doi: 10.1016/j.ijpharm.2013.08.044. Epub 2013 Sep 2. PubMed PMID: 24008082. 12: Mohammed D, Matts PJ, Hadgraft J, Lane ME. In vitro-in vivo correlation in skin permeation. Pharm Res. 2014 Feb;31(2):394-400. doi: 10.1007/s11095-013-1169-2. Epub 2013 Aug 14. PubMed PMID: 23943545. 13: Sadecka E, Szeląg H. One-Step Synthesis of W/O and O/W Emulsifiers in the Presence of Surface Active Agents. J Surfactants Deterg. 2013 May;16(3):305-315. Epub 2012 Sep 25. PubMed PMID: 23606803; PubMed Central PMCID: PMC3629284. 14: Hirata K, Helal F, Hadgraft J, Lane ME. Formulation of carbenoxolone for delivery to the skin. Int J Pharm. 2013 May 20;448(2):360-5. doi: 10.1016/j.ijpharm.2013.03.045. Epub 2013 Mar 29. PubMed PMID: 23545397. 15: Fisher S, Wachtel EJ, Aserin A, Garti N. Solubilization of simvastatin and phytosterols in a dilutable microemulsion system. Colloids Surf B Biointerfaces. 2013 Jul 1;107:35-42. doi: 10.1016/j.colsurfb.2013.01.036. Epub 2013 Jan 23. PubMed PMID: 23466540. 16: Fanun M, Papadimitriou V, Xenakis A. Characterization of cephalexin loaded nonionic microemulsions. J Colloid Interface Sci. 2011 Sep 1;361(1):115-21. doi: 10.1016/j.jcis.2011.05.042. Epub 2011 May 23. PubMed PMID: 21658706. 17: Kim KH, Gwak HS. Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin. Drug Dev Ind Pharm. 2011 Sep;37(9):1125-30. doi: 10.3109/03639045.2011.561352. Epub 2011 Mar 21. PubMed PMID: 21417615. 18: Moench TR, Mumper RJ, Hoen TE, Sun M, Cone RA. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect Dis. 2010 Nov 18;10:331. doi: 10.1186/1471-2334-10-331. PubMed PMID: 21087496; PubMed Central PMCID: PMC2996397. 19: Amsalem O, Aserin A, Garti N. Phospholipids-embedded fully dilutable liquid nanostructures. Part 2: The role of sodium diclofenac. Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):422-9. doi: 10.1016/j.colsurfb.2010.07.032. Epub 2010 Jul 21. PubMed PMID: 20708909. 20: Seo DW, Kang MJ, Sohn Y, Lee J. Self-microemulsifying formulation-based oral solution of coenzyme Q10. Yakugaku Zasshi. 2009 Dec;129(12):1559-63. PubMed PMID: 19952537.